6/5/2014 9:16:29 AM
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq: AFFX) and BioDiscovery, Inc. today announced the launch of a new analysis software, Nexus Copy Number for Affymetrix, which is specifically for data generated by Affymetrix’ genetic analysis platforms in cancer research, including CytoScan® Cytogenetics Suite and OncoScan® FFPE Assay Kit.
Help employers find you! Check out all the jobs and post your resume.
comments powered by